Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Chr. Hansen Holding A/S
  6. News
  7. Summary
    CHR   DK0060227585

CHR. HANSEN HOLDING A/S

(CHR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

UPL Ltd. Announces Long-Term Strategic Collaboration with Chr. Hansen to Develop and Commercialize Microbial-Based Biosolutions for Sustainable Agriculture

10/15/2021 | 01:01pm EST

UPL Ltd. has announced a long-term strategic collaboration with Chr. Hansen to develop microbial-based biosolutions (including biostimulants and biopesticides) that will help growers around the world fight pests and diseases, and improve crop quality and yields. Through this collaboration, UPL will use its global presence to undertake research and identify opportunities and product concepts to address farmers' pain points. From these insights, Chr. Hansen will design biological products based on their microbial capabilities and UPL will register and commercialize these products via its extensive global distribution network. The UPL-Chr. Hansen partnership has already identified several projects relevant to farmers globally and aims to develop a product pipeline for all major crops that will enable farmers to fight crop diseases and increase their yields. The companies are expecting the first registrations to start coming by the end of 2022.


ę S&P Capital IQ 2021
All news about CHR. HANSEN HOLDING A/S
12/01CHR HANSEN A/S : Fermentation-enabled bioprotection secures Chr. Hansen innovation award
PU
11/26CHR HANSEN A/S : AGM 2021 Votes cast
PU
11/25CHR. HANSEN HOLDING A/S : Ex-dividend day for final dividend
FA
11/24Resolutions passed at the Annual General Meeting of Chr. Hansen Holding A/S
AQ
11/24Chr. Hansen Holding A/S Approves Dividend
CI
11/16CHR HANSEN A/S : SWEETY« Y-3 culture adds new, fermentation-powered capabilities to Chr. H..
PU
11/15CHR HANSEN A/S : . Hansen launches science-based climate targets and embarks on a focused...
PU
11/10Lonza JV Bacthera, Seres to Jointly Produce Potential Gut Infection Treatment
MT
11/10Bacthera and Seres Therapeutics Collaborate for Commercial Manufacturing of SER-109, a...
PU
11/03Chr. Hansen tops the list of best Danish websites
PU
More news
Analyst Recommendations on CHR. HANSEN HOLDING A/S
More recommendations
Financials
Sales 2022 1 153 M 1 306 M 1 306 M
Net income 2022 231 M 262 M 262 M
Net Debt 2022 881 M 999 M 999 M
P/E ratio 2022 37,9x
Yield 2022 1,41%
Capitalization 8 745 M 9 919 M 9 909 M
EV / Sales 2022 8,35x
EV / Sales 2023 7,78x
Nbr of Employees 3 702
Free-Float 77,8%
Chart CHR. HANSEN HOLDING A/S
Duration : Period :
Chr. Hansen Holding A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHR. HANSEN HOLDING A/S
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Last Close Price 66,42 €
Average target price 70,11 €
Spread / Average Target 5,56%
EPS Revisions
Managers and Directors
Mauricio Graber President & Chief Executive Officer
Lise Skaarup Mortensen Chief Financial Officer & Executive Vice President
Dominique Reiniche Chairman
Thomas Schńfer Chief Scientific Officer & Executive VP
Winnie Hojvang BŘgel VP-Compliance & Corporate Communications